Kodiak Sciences Inc. IPO Research Information

Kodiak Sciences Inc. IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Kodiak Sciences Inc., and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Kodiak Sciences Inc.	KOD - NASDAQ	$13.00-$15.00	$10.00	$10.00	9 million	10/4/2018
Underwriter(s): Morgan Stanley, BofA Merrill Lynch
Co-Manager(s): Barclays, Chardan
Industry: Health Care
Filing(s): Filed 2018-09-07 Terms Added 2018-09-24

Kodiak Sciences Inc. Quote & Chart - Click for current quote - KOD

About Kodiak Sciences Inc. (adapted from Kodiak Sciences Inc. prospectus):
They are a clinical stage biopharmaceutical company specializing in novel therapeutics to treat chronic, high-prevalence retinal diseases.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "KOD" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.